Targeting the MALAT1-miR-206-GLS axis enhances the apoptotic effects of gastric cancer cells by mild hyperthermia treatments

Huijuan Shi, Kejun Li, Jinxin Feng, Gaojie Liu, Yanlin Feng, Xiangliang ZhangResearch 2020 · DOI

Introduction

Gastric cancer (GC) remains a significant global health challenge, often requiring multi-modal treatment strategies. Hyperthermia (HT), the application of heat to induce cancer cell death, has emerged as a promising adjunctive therapy. However, its clinical utility is often hampered by the "selectivity" problem: while high temperatures are effective, they risk damaging healthy tissue. Conversely, mild hyperthermia is safer but frequently triggers adaptive survival mechanisms in cancer cells, allowing them to resist thermal stress. This study identifies the long non-coding RNA (lncRNA) MALAT1 as a key regulator of this survival response through the modulation of glutamine metabolism.

The MALAT1-miR-206-GLS Regulatory Axis

The researchers investigated the molecular "shield" that protects GC cells during heat stress. They identified a signaling axis involving MALAT1, the microRNA miR-206, and glutaminase (GLS). MALAT1 functions as a competing endogenous RNA (ceRNA), acting as a molecular "sponge" that binds to and inhibits miR-206. Under normal conditions, miR-206 suppresses the expression of GLS, a critical enzyme in glutamine metabolism. By sequestering miR-206, MALAT1 effectively "releases the brakes" on GLS, fueling the metabolic pathways that support cancer cell survival.

Methods

To map this signaling pathway, the researchers utilized a multi-disciplinary approach. They analyzed 30 pairs of gastric cancer and adjacent normal tissues to establish clinical correlations. Molecular interactions were verified using luciferase reporter assays, which confirmed that MALAT1 directly sponges miR-206 and that miR-206 targets the 3’UTR of the GLS gene. Functional changes were assessed through glutamine uptake assays, GLS enzyme activity measurements, and MTT assays for cell viability. Hyperthermia was simulated by exposing cell cultures to temperatures between 37°C and 45°C for durations ranging from 30 minutes to 4 hours.

Clinical Relevance and Thermal Response

Analysis of patient tissues revealed that MALAT1 is significantly overexpressed in gastric cancer compared to adjacent normal tissues. High levels of MALAT1 and low levels of miR-206 were strongly correlated with poorer patient survival rates.

Figure 1: MALAT1 expression in gastric cancer and its adaptive response to thermal stress.

Crucially, the study found that mild hyperthermia (41–43°C) acts as a trigger for this pathway. Short-term exposure to heat induces MALAT1 expression, which in turn boosts glutamine uptake and GLS activity. This metabolic surge represents an adaptive reaction that helps the cell endure thermal stress. As shown in Figure 1, MALAT1 levels increase significantly at 41°C and 43°C, correlating with increased glutamine uptake and GLS activity.

Enhancing Hyperthermia-Induced Apoptosis

By targeting this axis, the researchers demonstrated a method to overcome heat resistance. Silencing MALAT1 or overexpressing miR-206 disrupted the metabolic "shield," significantly sensitizing GC cells to mild hyperthermia. When MALAT1 knockdown was combined with 41°C heat treatment, there was a dramatic increase in Caspase-3 activity and a corresponding decrease in cell viability, indicating a synergistic induction of apoptosis.

The "rescue" experiments were particularly definitive. When researchers manually restored GLS expression in cells where miR-206 was overexpressed, the inhibitory effects on glutamine metabolism and the increased sensitivity to heat were reversed. This confirms that the MALAT1-miR-206 axis exerts its influence primarily through the regulation of GLS-mediated glutamine metabolism.

Conclusion

The MALAT1-miR-206-GLS axis represents a critical metabolic vulnerability in gastric cancer. Targeting this pathway—either by inhibiting the lncRNA MALAT1 or boosting miR-206—offers a strategic approach to enhance the selectivity and efficacy of mild hyperthermia treatments. While further in vivo studies are necessary to validate these findings in complex biological systems, this research provides a clear molecular framework for improving outcomes in gastric cancer therapy.

Summary updated

Abstract

Abstract Background: To explore the molecular mechanisms and modulatory effects of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in the hyperthermia-induced gastric cancer cell death. Methods: Combined qRT-PCR and GLS activity detection of glutamine metabolism, we demonstrate the difference of expression of MALAT1 and miR-206 in normal or cancer tissue/ several cell lines and the roles of two in regulation of glutamine, respectively. The relation of MALAT1 and miR-206 was research by bioinformatical analysis and luciferase report. In addition, the molecular regulation between apoptotic effects and MALAT1-miR-206-GLS axis in gastric cancer after mild hyperthermia treatments were discovered by western blotting, luciferase report, quantitative real-time PCR (qRT-PCR), GLS activity detection of glutamine metabolism and cell viability test. Results: MALAT1 positively associated with GC by promoting glutamine metabolism under short time hyperthermia treatment, it involved in an adaptive reaction, an increased glutamine metabolism rate which could be further overridden by long time hyperthermia exposures. miR-206 could inhibit glutamine metabolism of GC and target 3’UTR of GLS which has oncogenic functions in GC directly. In addition, miR-206-suppresed glutamine metabolism was through direct targeting GLS. LncRNA MALAT1 inhibited miR-206 expression in GC by sponging it as a competing endogenous RNA. In summary, MALAT1-promoted glutamine metabolism was through the miR-206-GLS axis. Furthermore, we demonstrated effective approaches from the MALAT1-miR-206 axis for enhancing the mild hyperthermia-induced cancer death under a short time. Conclusions: Taken together, the MALAT1-miR-206-glutamine metabolism axis is a new strategy for enhancing the selectivity of hyperthermia treatments specific to GC cells
BibTeX
@inproceedings{shi2020targeting,
  author = {Huijuan Shi and Kejun Li and Jinxin Feng and Gaojie Liu and Yanlin Feng and Xiangliang Zhang},
  title = {{Targeting the MALAT1-miR-206-GLS axis enhances the apoptotic effects of gastric cancer cells by mild hyperthermia treatments}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-16238/v1},
}
Figure